In total, we included 497 HR+/HER2- breast cancer samples from TCGA for DEG analysis and integrated nine GEO datasets (n = 956) divided into two cohorts for biomarker identification between pCR and RD groups. This evidence concerns the gene ERBB2 and breast carcinoma.